Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its chiral structure supports selective binding to target proteins, enhancing drug efficacy and reducing off-target effects. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the stability and modifiability of the carbamate group. Also utilized in the preparation of proteolysis-targeting chimeras (PROTACs) where precise molecular recognition is critical.